Cargando…

Potential Biomarker for Human Uterine Leiomyosarcoma

Detalles Bibliográficos
Autores principales:	Hayashi, Takuma, Horiuchi, Akiko, Aburatani, Hiroyuki, Ishiko, Osamu, Yaegashi, Nobuo, Kanai, Yae, Zharhary, Dorit, Shiozawa, Tanri, Tonegawa, Susumu, Konishi, Ikuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125337/ https://www.ncbi.nlm.nih.gov/pubmed/25110546 http://dx.doi.org/10.14740/jocmr1867e

Ejemplares similares

Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011)

Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma
por: Hayashi, Takuma, et al.
Publicado: (2011)

Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy
por: Hayashi, Takuma, et al.
Publicado: (2011)

Profiling of Target Molecules for Immunotherapy in Mesenchymal Tumors
por: Hayashi, Takuma, et al.
Publicado: (2019)

Molecular Mechanisms of Uterine Leiomyosarcomas: Involvement of Defect in LMP2 Expression
por: Hayashi, Takuma, et al.
Publicado: (2008)

Importance of diagnostic methods for round ligament leiomyomas in clinical practice
por: Hayashi, Takuma, et al.
Publicado: (2023)

Molecular pathological approach of uterine intravenous leiomyomatosis
por: Hayashi, Takuma, et al.
Publicado: (2022)

Characteristic of Uterine Rhabdomyosarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor
por: Tamura, Saya, et al.
Publicado: (2022)

Characteristic of Concurrent Uterine Lipoleiomyoma and Hemangioma by Algorithm of Candidate Biomarkers for Uterine Mesenchymal Tumor
por: Nishikawa, Shoko, et al.
Publicado: (2022)

Characteristic of Endometrial Stromal Sarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor
por: Hayashi, Takuma, et al.
Publicado: (2023)

Abstract 153: Examination of the affinity of anti-SARS-CoV-2 IgA, which is mucosal immunity, for SARS-CoV-2 BA.4 variant and BA.5 variant
por: Hayashi, Takuma, et al.
Publicado: (2023)

Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer
por: Hayashi, Takuma, et al.
Publicado: (2022)

Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin
por: Suzuki, Akihisa, et al.
Publicado: (2010)

Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals
por: Hayashi, Takuma, et al.
Publicado: (2020)

Notes on the morphological features of cotyledonary dissecting leiomyoma, which is rare in clinical practice
por: Tamura, Saya, et al.
Publicado: (2023)

Expression of steroid and xenobiotic receptor in uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma
por: YUE, XIAONI, et al.
Publicado: (2013)

Potential Biomarkers Associated With the Nature of Uterine Benign Mesenchymal Tumors
por: Tamura, Saya, et al.
Publicado: (2022)

Oncological Properties of Intravenous Leiomyomatosis: Involvement of Mesenchymal Tumor Stem-Like Cells
por: Tamura, Saya, et al.
Publicado: (2021)

Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)

Leiomyosarcoma after Total Laparoscopic Hysterectomy with Power Morcellation
por: Takahashi, Tsukasa, et al.
Publicado: (2019)

Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
por: Lamm, Wolfgang, et al.
Publicado: (2014)

Uterine leiomyosarcoma: A case report
por: Kaur, Khushpreet, et al.
Publicado: (2014)

Prevalence and occult rates of uterine leiomyosarcoma
por: Wang, Lingxiang, et al.
Publicado: (2020)

A Case Report Of Uterine Leiomyosarcoma
por: Cao, Siyu, et al.
Publicado: (2019)

The Role of Hedgehog Pathway in Uterine Leiomyosarcoma
por: Garcia, Natalia, et al.
Publicado: (2021)

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016)

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma
por: Tsuyoshi, Hideaki, et al.
Publicado: (2018)

Perforated intestinal leiomyosarcoma as a metastasis of uterine leiomyosarcoma: a case report
por: Saylam, Barış, et al.
Publicado: (2009)

Cervical leiomyosarcoma in a teenage girl: A rare form of uterine leiomyosarcoma()
por: Adewole, Adebayo A., et al.
Publicado: (2021)

Utility of Laparoscopic Uterine Myomectomy as a Treatment for Infertility with No Obvious Cause Except for Uterine Fibroids
por: Kameda, Satomi, et al.
Publicado: (2018)

Vulvar Leiomyosarcomas: A Case Series with Clinical Comparison to Uterine Leiomyosarcomas and Review of the Literature
por: Verta, Stephanie, et al.
Publicado: (2023)

Uterine leiomyosarcoma with central nervous system metastases
por: Abrahão, Carina Meira, et al.
Publicado: (2015)

Rare Endobronchial metastasis from uterine leiomyosarcoma
por: Ghosh, Saswata, et al.
Publicado: (2015)

A Case of Renal Metastasis of Uterine Leiomyosarcoma
por: Bajic, Petar, et al.
Publicado: (2017)

Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells
por: de Almeida, Bruna Cristine, et al.
Publicado: (2017)

Targeting homologous recombination deficiency in uterine leiomyosarcoma
por: Dall, Genevieve, et al.
Publicado: (2023)

A Rare Case of Uterine Myxoid Leiomyosarcoma
por: Wankhade, Rashmi, et al.
Publicado: (2023)

αGlcNAc and its catalyst α4GnT are diagnostic and prognostic markers in uterine cervical tumor, gastric type
por: Ida, Koichi, et al.
Publicado: (2019)

Correlation of anti-tumour drug resistance with epigenetic regulation
por: Hayashi, Takuma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c85vebg67u3slnubt78uuv4mg9